Fisher & Paykel is well-positioned to benefit from long-term growth prospects in hospital and home respiratory care. Increasing adoption of nasal high flow, or NHF, therapy in the hospital division is ...
Fisher & Paykel Healthcare is located on a campus named for one of its founders in a section of East Tāmaki, Auckland, close to the industrial highways that supply the southern end of New Zealand’s ...
Financial News: Fisher and Paykel Healthcare Shares , From NZ$0.40 in 1993 to a Record-Breaking Run in 2026 — Here’s the State of FPH Today
Fisher and Paykel Healthcare Shares , From NZ$0.40 in 1993 to a Record-Breaking Run in 2026 — Here’s the State of FPH Today
The New England Journal of Medicine: High-Flow Oxygen with Capping or Suctioning for Tracheostomy Decannulation
The New England Journal of Medicine: High-Flow or Standard Oxygen in Acute Hypoxemic Respiratory Failure
Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic respiratory ...
Healio: Use of high-flow nasal cannula oxygen therapy at home may reduce COPD exacerbations
Please provide your email address to receive an email when new articles are posted on . The addition of high-flow nasal cannula to long-term oxygen therapy may ...
Use of high-flow nasal cannula oxygen therapy at home may reduce COPD exacerbations
Fisher Chemical™ Optima™ LC/MS grade solvents, reagents, and mobile phase blends set the standard for consistent, reproducible performance. Extensive testing shows minimal metal impurities, low background noise, and the lowest impurity background using diode array detection.